We are beyond excited to announce Reverse Rett NYC 2022, our first in-person event in three years. Research on Rett has continued to make remarkable progress. The first human clinical trial for Rett in gene replacement is launching this year. That's your past support in action for our loved ones and 350,000 others with Rett. Our beneficiary, the Rett Syndrome Research Trust, has spurred all this progress on. Your support this year, at as generous a level as possible, is more important than ever. Every sponsorship, donation, and ticket purchase helps keep this exciting scientific momentum going. Thank you!